Companies in #Clinical Diagnostics
Found 2 companies operating in this sector.
Illumina (NASDAQ: ILMN) is the dominant maker of DNA sequencing machines and integrated genomics platforms, with installed instruments across academic, clinical, and pharmaceutical research worldwide. The San Diego-based company sells the NovaSeq X, NextSeq, and MiSeq lines of sequencing systems, the TruSight and AmpliSeq targeted-resequencing portfolios, and the DRAGEN secondary-analysis software. Illumina is also pushing into clinical sequencing through its Illumina Connected Software and the TruSight Oncology Comprehensive genomic profiling assay, and spun off its GRAIL liquid-biopsy subsidiary in 2024.
Trinity Biotech plc is a commercial-stage biotechnology company headquartered in Dublin, Ireland, focused on human diagnostics and diabetes management solutions including wearable biosensors. The company develops, acquires, manufactures, and markets diagnostic systems for the point-of-care and clinical laboratory segments and has expanded into the wearable biosensor and data-center liquid-cooling infrastructure segments through recent acquisitions. Trinity Biotech is dual-listed on Nasdaq and announced a 1-for-30 reverse ADS split in July 2026 intended to regain Nasdaq minimum-bid-price compliance.